Tirbanibulin, marketed under the brand name Klisyri, is a topical ointment used primarily to treat actinic keratosis, a skin condition caused by repeated exposure to ultraviolet light from the sun or indoor tanning. Tirbanibulin was approved by the US Food and Drug Administration (FDA) on December 14, 2020, for the treatment of actinic keratosis on the face or scalp.
Uses:
Administration:
Common Side Effects:
Serious Side Effects:
If any severe side effects occur, contact your doctor immediately. You can report side effects to the FDA at 1-800-FDA-1088.
Topical medications like tirbanibulin are unlikely to interact with other drugs you use. However, it is essential to inform your healthcare providers about all the medications you are taking, including prescription drugs, over-the-counter medicines, vitamins, and herbal products.
This medication offers a targeted treatment option for patients with this condition. As with all medications, it is crucial to follow the prescribed instructions and consult your healthcare provider with any concerns or questions regarding its use.
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!